Production of neutralizing monoclonal antibody against human vascular endothelial growth factor receptor II.
Li
Rong
R
State Key Laboratory of Experimental Hematology, Institute of Hematology, Chinese Academy of Medical Science and Peking Union Medical College,Tianjin 300020, China.
Xiong
Dong-Sheng
DS
Shao
Xiao-Feng
XF
Liu
Jia
J
Xu
Yuan-Fu
YF
Xu
Yuan-Shen
YS
Liu
Han-Zhi
HZ
Zhu
Zhen-Ping
ZP
Yang
Chun-Zheng
CZ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism / Q000494:pharmacology*; D002460:Cell Line; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D042783:Endothelial Cells / Q000378:metabolism; D004926:Escherichia coli / Q000378:metabolism; D006801:Humans; D007128:Immunoglobulin Fragments / Q000276:immunology / Q000378:metabolism; D008546:Melanoma, Experimental / Q000473:pathology; D051379:Mice; D008807:Mice, Inbred BALB C; D008938:Mitosis / Q000187:drug effects; D010766:Phosphorylation; D011993:Recombinant Fusion Proteins / Q000276:immunology / Q000378:metabolism; D014471:Umbilical Veins / Q000166:cytology; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000276:immunology / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D007128:Immunoglobulin Fragments; D011993:Recombinant Fusion Proteins; D042461:Vascular Endothelial Growth Factor A; D040301:Vascular Endothelial Growth Factor Receptor-2